
PATIENT TERMS OF USE FOR THE «instapharm» APP (Όροι Χρήσης)
Version: 1.0 (Beta) Effective date: 1 July 2026
Welcome to the «instapharm» app. Before you create an account and use the app, please read these Terms of Use carefully. By accepting them when you create your account, you enter into a contract with Materia Technica P.C. If you do not agree with any term, please do not use the app.
Your acceptance is recorded by the app together with the following details: date and time, the version of these Terms of Use, the URL of the text, a copy of the text shown to you, IP address and device characteristics, as evidence of the conclusion of a contract in accordance with Greek law.
In parallel with these Terms, the Personal Data Processing Notice applies (the public version is provided at https://instapharm.app/privacy). Please also read that Notice.
1.1. These Terms of Use are concluded electronically and at a distance between:
(a) MATERIA TECHNICA P.C. (trading as "MATERIA TECHNICA"), a private capital company (Ι.Κ.Ε.), having its seat in Pefki, Attica, at 8A Saki Karagiorga Street, 15121, VAT No. 802200695, Tax Office of Amarousio, G.E.MI. No. 171973201000 (hereinafter "Materia Technica", the "Provider" or "we"),
(b) and the User, being the natural person who creates a patient account in the «instapharm» app (hereinafter the "Patient", "User" or "you").
1.2. The subject matter of these Terms of Use is to set out the terms under which Materia Technica provides the Patient with access to and use of the «instapharm» mobile application (hereinafter the "App").
"App" / "Service": the «instapharm» mobile application, which allows patients to coordinate the dispensing of their electronic prescriptions through connected pharmacies and IDIKA (the national e-prescription system operator), to authorise a third person to collect medicines on their behalf, and to receive notifications relating to the dispensing of their prescriptions.
"Account": the unique Patient user-account in the App, identified with the Patient's mobile telephone number.
"Pharmacy": a licensed pharmacy that dispenses electronic prescriptions through the «instapharm» platform, to which the Patient has chosen to connect.
"Beta": the commercial trial period of the platform, lasting six (6) months from launch and until 31 December 2026 at the latest.
"Data Protection Notice": the Patient Personal Data Processing Notice (B2 — Article 13 GDPR), which is an integral frame of reference but not part of this contract.
3. PRE-CONTRACTUAL INFORMATION (Article 3a of Law 2251/1994)
Before your acceptance, we give you the following information:
3.1. Identity and contact details of the Provider: as set out in Article 1.1(a) above. Contact email for contractual matters: legal@materiatechnica.com / legal@materia-labs.ai. Contact email for personal-data matters: privacy@materiatechnica.com / privacy@materia-labs.ai.
3.2. Main characteristics of the Service: the App is a pharmacy- coordination platform for the Patient. The App does not provide medical, pharmaceutical or therapeutic advice, nor does it constitute a medical aid or a medical device. See in particular Section 5 below.
3.3. Price: the App is provided free of charge to the Patient during the Beta. No payment, subscription or other financial charge is required from you. See in particular Section 9.
3.4. Means of payment: not applicable (free Service).
3.5. Duration of the contract: of indefinite term, until terminated by either Party under Sections 13 and 14, or until the end of the Beta on the new terms announced by Materia Technica.
3.6. Minimum duration of obligations: no minimum-duration obligation — you may delete your Account at any time.
3.7. Right of withdrawal and immediate commencement of performance:
(a) As a consumer resident in Greece, you have, in principle, the right to withdraw from this contract without giving any reason within fourteen (14) calendar days of its conclusion, in accordance with Articles 3e et seq. of Law 2251/1994. To exercise this right you may use the model withdrawal form in Annex A, although this is not mandatory; any clear statement of your decision to withdraw suffices, by sending an email to legal@materiatechnica.com or by deleting your Account through the App within the deadline.
(b) Immediate commencement — loss of the right of withdrawal. The App is a digital service that is not supplied on a tangible medium and whose performance begins as soon as you create an Account. For this reason, when you create your Account (Section 4.4), you are asked: (i) to give your express, prior consent to the immediate commencement of performance of the Service within the withdrawal period, and (ii) to acknowledge that, upon the full performance of the Service following your consent, you lose your right of withdrawal, in accordance with Article 3ιβ, point (ιγ), of Law 2251/1994. If you do not give the above express consent and acknowledgement, the fourteen (14)-day right of withdrawal is retained in full under point (a). During the Beta this separate express consent is not presented separately (see Section 4.4); consequently, the fourteen (14)-day right of withdrawal is retained in full.
(c) Given that the Service is provided free of charge, neither withdrawal nor loss of the right of withdrawal entails any financial consequence for you. In any event, regardless of withdrawal, you may delete your Account at any time under Section 13.
3.8. Complaints procedure: by email to legal@materiatechnica.com. We undertake to respond within a reasonable time, and at the latest within thirty (30) days of receipt.
3.9. Out-of-court dispute resolution: you may address yourself to the Consumer Ombudsman (144 Alexandras Avenue, 11471 Athens, www.synigoroskatanaloti.gr), to the local Amicable Settlement Committees of the Municipalities, or to an Alternative Dispute Resolution (ADR) body registered in accordance with Joint Ministerial Decision 70330oik./2015. The European Commission's online Dispute Resolution (ODR) platform is also available at https://ec.europa.eu/consumers/odr/.
3.10. Functionality and interoperability: the App runs on devices with Android version 7.0 or later (API level 24) and iOS version 15.1 or later. Use requires an internet connection and a mobile telephone number that can receive SMS or OTP calls.
4.1. Acceptance of these Terms takes place electronically when you create your Account, by means of a confirmatory action ("click-wrap").
4.2. Upon your acceptance, Materia Technica records the evidence of conclusion of the contract referred to in the introduction to these Terms (version, URL, copy of the text, IP, device characteristics, timestamp).
4.3. The contract is concluded in electronic form and is not archived on paper. You may, however, request a copy of the Terms you accepted (including the version in force at the time of your acceptance) by email to legal@materiatechnica.com.
4.4. Express consent to immediate commencement and acknowledgement of loss of the right of withdrawal. The above express consent and acknowledgement presupposes a separate confirmatory action, distinct from the general acceptance of these Terms, by a declaration with the following content:
"I expressly consent to the immediate commencement of the provision of the Service within the withdrawal period and acknowledge that, upon its full performance, I lose my right of withdrawal (Article 3ιβ, point (ιγ), of Law 2251/1994)."
During the Beta this separate declaration is not presented separately: acceptance upon creation of the Account is made by a single confirmatory action (one common field accepting the Terms of Use and the Data Protection Notice). Since the above separate express consent and acknowledgement is not given, no loss of the right of withdrawal occurs and you retain in full the fourteen (14)-day right of withdrawal under Section 3.7(a). You also receive in advance the model withdrawal form in Annex A and the full pre-contractual information of Section 3 (Article 3b of Law 2251/1994).
5.1. What the App is: a coordination tool between the Patient and the pharmacy / pharmacies with which the Patient chooses to connect. It allows the Patient: (a) to be identified remotely at their pharmacy, (b) to track the status of their electronic prescriptions through the IDIKA interface, as exposed by the pharmacy, (c) to authorise a third person to collect medicines on their behalf, (d) to receive functional notifications relating to their prescriptions.
5.2. What the App is NOT: (a) The App does not provide medical, pharmaceutical or therapeutic advice. (b) The App is not a medical device within the meaning of Regulation (EU) 2017/745. (c) The App does not replace your consultation with your doctor or pharmacist. (d) The App does not itself dispense prescriptions — dispensing is carried out by the responsible pharmacist of your pharmacy, in accordance with applicable law and the rules of pharmaceutical ethics (Presidential Decree 340/1993). (e) The App does not make automated decisions that significantly affect you within the meaning of Article 22 GDPR. See also Section XIII of the Data Protection Notice.
5.3. For any question of a clinical, pharmacological or therapeutic nature, please consult your pharmacist or doctor.
6.1. Use for yourself. You may use the App to coordinate your own electronic prescriptions and your own medication reminders.
6.2. Use for a dependant. If you exercise parental care, guardianship or another lawful power of representation under Greek law, you may also use the App for a child or other dependant whose care you lawfully manage. By using the App for such a person, you declare that you are lawfully authorised to act on their behalf as regards prescription coordination, reminders, communications and the medicine-collection settings linked to the dispensing pharmacy. Materia Technica may request additional supporting evidence only where this is reasonably necessary (e.g. non-parent representatives, known custody restrictions, conflicting claims). Specifically for a minor child, representation is organised through a dependant profile: you register the child's AMKA (social- security number) and sign a solemn declaration of guardianship, which grants access only to that specific minor's data, for that specific pharmacy, and terminates automatically when they reach the age of 18.
6.3. Processing for care purposes. The App's core care-coordination and prescription-dispensing functions process health data because this is necessary for the provision and coordination of healthcare by the dispensing pharmacy (Article 9(2)(h) GDPR in conjunction with Article 22(1)(b) of Law 4624/2019). This processing is not subject to the age threshold of fifteen (15) years, which concerns exclusively processing based on consent.
6.4. Optional consent-based features. Where the App offers an optional feature that relies on consent (e.g. promotional or informational communications) and the User is under fifteen (15) years of age, that consent must be given or approved by their legal representative (Article 21 of Law 4624/2019). The 15-year threshold applies at the point of activation of the relevant optional feature, by a simple declaration, and not as a general age limit upon creation of an Account.
6.5. Minors aged 15-17. A minor User aged 15-17 may use the App for their own already-prescribed prescriptions. The App does not create the prescription, nor the right to have it dispensed — it merely organises an already-lawful care process. Informing and obtaining the consent of those who exercise parental care is desirable and not mandatory. For a child under 15, use takes place through the representation under Section 6.2 by the person exercising parental care or the legal representative (Articles 1510 and 1516 of the Civil Code), and not through a separate account of the child themselves.
6.6. Collection of medicines. The actual collection of medicines continues to be governed by the identification and authorisation rules of the dispensing pharmacy and the prescription-dispensing process of IDIKA/EOPYY (the patient, first- or second-degree relatives, or an authorised third person holding an authorisation/solemn declaration). A parent who collects medicines for their child on the basis of the child's AMKA does not need a special authorisation (as a first-degree relative).
6.7. Your declarations. By accepting these Terms you declare that: (a) the identification details you provide are true and accurate, and (b) you have the capacity and/or power under the Civil Code (in particular Articles 127-129, 1510, 1516 CC) to conclude this contract for yourself and/or to act for the dependant you lawfully represent.
7.1. Use of the App requires the creation of an Account.
7.2. Authentication is carried out by sending a one-time password (OTP — One Time Password) by SMS to the mobile telephone number you have declared. By declaring that number you confirm that you are the lawful holder of, or a lawfully authorised user of, that number.
7.3. One Account per Patient. The creation of multiple Accounts by the same natural person is not permitted.
7.4. In the event of loss of your device, change of mobile number or other inability to access your Account, please contact privacy@materiatechnica.com / privacy@materia-labs.ai. Materia Technica will support you in recovering access on a "best-efforts" basis and after confirmation of your identity.
7.5. Account security. You are responsible for safeguarding your device and the mobile number you use for authentication. Materia Technica is not liable for use of your Account by a third person who has gained access to your device or your number, unless such access is due to a breach of a security obligation of our own.
8.1. Use of the App is permitted solely for the purposes described in Section 5 and in accordance with these Terms.
8.2. The following are prohibited: (a) accessing the prescription data of a third person without valid authorisation through the App, (b) the impersonation of another patient, pharmacist or person, (c) automated data collection (scraping) or the use of bots, crawlers or other automated means without the written permission of Materia Technica, (d) any attempt to circumvent or undermine security measures (e.g. disabling encryption, exploiting vulnerabilities, reverse engineering), (e) using the App in a manner that violates Greek law (in particular pharmaceutical law and Presidential Decree 340/1993 on pharmaceutical ethics) or that prejudices the rights of third parties, (f) using the App for the trafficking of medicines in breach of the law on medicines.
8.3. A breach of this Section entitles Materia Technica to the immediate suspension of your access to the Account and/or to termination of the contract under Section 14.
9.1. The App is provided free of charge to the Patient. Materia Technica does not charge you any registration fee, subscription, pay-per-use charge, or other financial burden for use of the App.
9.2. The free-of-charge nature applies continuously throughout the Beta and for as long as Materia Technica does not decide otherwise. Should a charge for the Patient be introduced in the future, Materia Technica is obliged to inform you in advance and to ask for your renewed express consent. No charge will commence without your express acceptance.
9.3. The processing of your personal data in the context of the Service is governed by the Data Protection Notice (B2). The provision of data in the context of the App's operation does not constitute monetary consideration within the meaning of civil law, without, however, thereby setting aside the application of the GDPR and other personal-data legislation to that processing.
10.1. The App is in a commercial trial (Beta) phase. This means: (a) Materia Technica provides the Service on a "best-efforts" basis, without commitment to a specific level of availability, (b) there may be interruptions, errors, changes of functionality or temporary suspensions of features (e.g. for urgent security fixes), (c) certain features may be under development and may change or be withdrawn, (d) Materia Technica will endeavour to notify you in advance of planned changes, without this being a contractual obligation during the Beta.
10.2. The Beta phase does not in any way limit your rights as a consumer under Law 2251/1994 and other Greek and EU consumer-protection legislation.
11.1. Not medical advice. As provided in Section 5.2, the App does not provide medical, pharmaceutical or therapeutic advice. Materia Technica is not liable for clinical decisions or actions you take on the basis of information or notifications displayed in the App. Please consult your pharmacist or doctor.
11.2. Free Service — limited liability. Given that the Service is provided free of charge, Materia Technica's liability for damage of any kind is limited to the maximum extent permitted by law. The above limitations do not apply, and Materia Technica is fully liable under the general provisions, for: (a) intent and gross negligence — any advance discharge or limitation of liability for intent or gross negligence is void (Article 332 CC), (b) death, bodily injury or harm to health caused by its culpable act or omission, (c) liability arising from mandatory-law provisions, in particular the legal guarantee and the rights for non-conformity of digital content or a digital service (Article 3b, point (ιβ), of Law 2251/1994 and Articles 534 et seq. CC), and (d) any other liability that, by law, may not be excluded or limited. No provision of this Section is intended to exclude or disproportionately limit liability in a manner that would be abusive within the meaning of Article 2(7) of Law 2251/1994.
11.3. Indirect damages. Materia Technica is not liable for indirect, consequential or incidental damages, in particular for lost profits, loss of use, loss of data (beyond the security measures of Article 32 GDPR that are applied), or non-pecuniary harm absent intent or gross negligence.
11.4. Relationship with the Pharmacy. The Pharmacy with which you choose to connect is an independent Controller for its own flows (see Section II of the Data Protection Notice) and has its own legal relationship with you as a patient. Materia Technica is not liable for acts or omissions of your Pharmacy, in particular for: (a) errors in the dispensing of an electronic prescription, (b) the availability or stock of medicines, (c) service times, (d) the handling of your personal data by the Pharmacy outside the Platform.
11.5. Third-party services. The operation of the App depends on third-party services (in particular: IDIKA, SMS and push-notification providers, internet providers, authentication providers). Materia Technica is not liable for interruptions, delays or failures of those services that are beyond its control.
11.6. Reservation in favour of consumer law. No provision of this Section affects the mandatory-law rights granted to you, as a consumer, by Law 2251/1994 and other Greek and EU consumer-protection legislation. In the event of conflict, the provisions more favourable to the consumer prevail.
12.1. All intellectual and industrial property rights in the App, the «instapharm» platform, the software, the graphic design, the trademarks and the databases belong to Materia Technica or its lawful licensors.
12.2. You are granted a limited, non-exclusive, non-transferable and revocable licence to use the App for strictly personal, non-commercial use, solely for the purposes of Section 5. This licence terminates automatically upon termination of the contract under Sections 13 and 14.
12.3. You acquire no right to copy, modify, distribute, sub-license, create derivative works of, or perform reverse engineering on the App.
13.1. You may terminate this contract and delete your Account at any time, without giving reasons and without financial charge.
13.2. Deletion is carried out: (a) within the App, through the delete-Account option in Settings (soft-delete: the Account is deactivated and access is cut off), or (b) by a request for permanent deletion to privacy@materiatechnica.com / privacy@materia-labs.ai (hard-delete: your data is permanently deleted following execution by the Privacy Lead, subject to the retention periods imposed by legal obligations — see Section IX of the Data Protection Notice).
13.3. Deletion of the Account does not affect: (a) prescription data already dispensed by Pharmacies — these are kept by your Pharmacy and/or IDIKA in accordance with their own legal obligations, beyond the control of Materia Technica, (b) the consent/registration evidence kept by Materia Technica (e.g. Terms version, URL, copy of the text, IP address, device characteristics, timestamp), for as long as provided in the Data Protection Notice.
14.1. Materia Technica reserves the right to suspend or terminate the contract and to deactivate your Account in the following cases: (a) material breach of Sections 6, 7, or 8 of these Terms, (b) reasonable suspicion of fraud, impersonation, or abuse of the App, (c) order of a competent authority or court, (d) upon the end of the Beta phase without continuation of the Service — with at least thirty (30) days' notice by email or in-app notification.
14.2. In all cases under Section 14.1 except (b) and (c) in an urgent case, Materia Technica will notify you in advance with reasonable notice, so that you have the opportunity to export your data or to exercise your rights under Articles 15-22 GDPR.
14.3. In the event of an urgent threat to the security of the Platform, other patients or Pharmacies, Materia Technica is entitled to immediately suspend your access, with or without prior notice, and to inform you afterwards as soon as possible.
15.1. Materia Technica reserves the right to amend these Terms of Use. The current version and the effective date appear at the beginning hereof.
15.2. Material amendments (e.g. pricing policy, material limitation of features, new liability terms) will be notified to you within the App. During the Beta the mechanism for mandatory re-acceptance of the new version is not yet activated; for this reason Materia Technica will not bring a material amendment into force during the Beta without first either activating a re-acceptance process for the new version or notifying you in advance, giving you the opportunity to terminate the contract under Section 13. In any event, if you do not accept a new version, you may terminate the contract under Section 13.
15.3. Non-material amendments (e.g. corrections of typographical errors, updating of contact details) take effect without renewed acceptance; the version number and effective date are updated.
15.4. All versions of the Terms that have ever been accepted are kept by Materia Technica and are available on request at legal@materiatechnica.com.
16.1. The processing of your personal data in the context of the App is carried out in accordance with the Patient Personal Data Processing Notice (B2 — Article 13 GDPR), which constitutes a frame of reference for these Terms without being part of this contract. Please read that Notice.
16.2. For questions or requests concerning your personal data, contact privacy@materiatechnica.com / privacy@materia-labs.ai.
17.1. For contractual matters (terminations, complaints, withdrawal, questions on the interpretation of these Terms): legal@materiatechnica.com / legal@materia-labs.ai.
17.2. For personal-data matters: privacy@materiatechnica.com / privacy@materia-labs.ai.
17.3. Materia Technica will communicate with you through the App (in-app notifications) and/or by email to the address you have declared (if you have declared one), and/or by SMS to the mobile number of your Account. A push-content opacity design rule applies as set out in Section VIII of the Data Protection Notice.
18.1. These Terms of Use are governed by Greek law.
18.2. Reservation in favour of the consumer. The rights granted to you as a consumer by Law 2251/1994 and other Greek and EU consumer-protection legislation are retained in full. As a consumer resident in Greece you have the right to bring proceedings before the courts of your place of residence in Greece.
18.3. Subject to Section 18.2, the Courts of Athens have jurisdiction to resolve any dispute that may arise from these Terms.
18.4. Before any recourse to the courts, we suggest that you use the out-of-court dispute-resolution means referred to in Section 3.9.
19.1. Entire agreement. These Terms, together with the Personal Data Processing Notice (B2), constitute the entire agreement between Materia Technica and the Patient as regards use of the App.
19.2. Severability. If a provision hereof is held void or unenforceable by a competent court or authority, the remaining provisions remain in full force. The void provision is replaced by a valid provision that comes as close as possible to the economic and legal purpose of the original.
19.3. No assignment by the Patient. You may not assign your rights under these Terms to a third party. Materia Technica is entitled to assign the contract to a lawful successor (e.g. in a corporate transformation), with prior notice to you.
19.4. Force majeure. Neither Party is liable for a breach of its obligation due to an event of force majeure (e.g. natural disasters, interruption of telecommunications beyond its control, orders of a public authority).
| Version | Date | Summary |
| 1.0 | 1 July 2026 | First version — start of Beta |
8A Saki Karagiorga Street, 15121, Pefki, Attica G.E.MI.: 171973201000 — VAT No.: 802200695, Tax Office of Amarousio Email for contractual matters: legal@materiatechnica.com / privacy@materia-labs.ai Email for personal-data matters: privacy@materiatechnica.com / privacy@materia-labs.ai
- Civil Code (in particular Articles 127-129 on capacity to perform legal acts, 332 on intent / gross negligence, 247-279 on limitation/prescription). - Law 2251/1994 on consumer protection, as amended (among others) by Law 4933/2022 (Directive 2019/2161 — modernisation of consumer protection). - Law 4967/2022 — transposition of Directive (EU) 2019/770 (digital content and services). - Directive 2011/83/EU on consumer rights. - Directive (EU) 2019/770 on digital content / services. - Regulation (EU) 2016/679 (GDPR). - Law 4624/2019 — national GDPR implementation measures; Article 21 age threshold. - Law 3471/2006 — protection of data in electronic communications. - Presidential Decree 340/1993 — Code of Pharmaceutical Ethics. - Regulation (EU) 2017/745 on medical devices (MDR) — referred to in order to confirm that the App does not fall within its scope. - Joint Ministerial Decision 70330oik./2015 — consumer Alternative Dispute Resolution (ADR).
(Article 3b of Law 2251/1994)
Complete and return this form only if you wish to withdraw from the contract and provided that you have not already lost the right of withdrawal under Section 3.7(b). Use of the form is not mandatory: any other clear statement of your decision suffices.
To: MATERIA TECHNICA P.C. 8A Saki Karagiorga Street, 15121, Pefki, Attica Email: legal@materiatechnica.com
I hereby give notice that I withdraw from the contract for the use of the «instapharm» app:
— Date of conclusion of the contract / creation of the account: ____________ — Consumer's full name: ____________ — Mobile number / account details: ____________ — Date: ____________ — Signature (only if this form is sent on paper): ____________
© 2026 Materia Technica P.C. All rights reserved.